Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven in Major Pelvic Fracture Surgery
NCT01601457Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2002
- Primary completion
- Apr 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of coagulation factor VIIa, sponsored by Novo Nordisk. Started Sep 2002; status: completed.
02
Drugs
coagulation factor VIIa
Beyond the preview
Go deeper on NCT01601457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601457.